← Back to Clinical Trials
Recruiting NCT04073420

NCT04073420 Medtronic Cardiac Surgery PMCF Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04073420
Status Recruiting
Phase
Sponsor Medtronic Cardiac Surgery
Condition Valve Disease, Heart
Study Type OBSERVATIONAL
Enrollment 2,700 participants
Start Date 2019-12-02
Primary Completion 2039-12-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Surgical Heart Valve Repair ProductsSurgical Heart Valve Replacement Products

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,700 participants in total. It began in 2019-12-02 with a primary completion date of 2039-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This registry is being conducted to support ongoing post-market surveillance activities.

Eligibility Criteria

Inclusion Criteria: 1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements 2. Patient has or is intended to receive or be treated with an eligible product 3. Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment Exclusion Criteria: 1. Patient who is, or is expected to be, inaccessible for follow-up 2. Patient prohibited from participation by local law 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results

Contact & Investigator

Central Contact

Lisa Slusser

✉ rs.hvtpmcfregistry@medtronic.com

📞 1-800-328-2518

Frequently Asked Questions

Who can join the NCT04073420 clinical trial?

This trial is open to participants of all sexes, studying Valve Disease, Heart. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04073420 currently recruiting?

Yes, NCT04073420 is actively recruiting participants. Contact the research team at rs.hvtpmcfregistry@medtronic.com for enrollment information.

Where is the NCT04073420 trial being conducted?

This trial is being conducted at Marietta, United States, Ann Arbor, United States, New York, United States, Roslyn, United States and 11 additional locations.

Who is sponsoring the NCT04073420 clinical trial?

NCT04073420 is sponsored by Medtronic Cardiac Surgery. The trial plans to enroll 2,700 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology